ArticleFrontiers in cardiovascular medicine2023

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure.

Zhenya Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.